FI892420A0 - Förfarande för framställning av terapeutiskt användbara 2-aminoetanolderivat - Google Patents

Förfarande för framställning av terapeutiskt användbara 2-aminoetanolderivat

Info

Publication number
FI892420A0
FI892420A0 FI892420A FI892420A FI892420A0 FI 892420 A0 FI892420 A0 FI 892420A0 FI 892420 A FI892420 A FI 892420A FI 892420 A FI892420 A FI 892420A FI 892420 A0 FI892420 A0 FI 892420A0
Authority
FI
Finland
Prior art keywords
preparation
therapeutically useful
aminoethanol derivatives
aminoethanol
derivatives
Prior art date
Application number
FI892420A
Other languages
English (en)
Finnish (fi)
Other versions
FI892420A (sv
FI90662B (sv
FI90662C (sv
Inventor
Angelo Carenzi
Dario Chiarino
Bella Davide Della
Gian Carlo Grancini
Carlo Veneziani
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT20648/88A external-priority patent/IT1217657B/it
Priority claimed from IT8919480A external-priority patent/IT1230754B/it
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of FI892420A0 publication Critical patent/FI892420A0/sv
Publication of FI892420A publication Critical patent/FI892420A/sv
Publication of FI90662B publication Critical patent/FI90662B/sv
Application granted granted Critical
Publication of FI90662C publication Critical patent/FI90662C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C07D211/76—Oxygen atoms attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI892420A 1988-05-20 1989-05-19 Förfarande för framställning av terapeutiskt användbara 2-aminoetanolderivat FI90662C (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IT20648/88A IT1217657B (it) 1988-05-20 1988-05-20 Composti con attivita' analgesica centrale
IT2064888 1988-05-20
IT8919480A IT1230754B (it) 1989-02-17 1989-02-17 Camposti con attivita' analgesica centrale.
IT1948089 1989-02-17

Publications (4)

Publication Number Publication Date
FI892420A0 true FI892420A0 (sv) 1989-05-19
FI892420A FI892420A (sv) 1989-11-21
FI90662B FI90662B (sv) 1993-11-30
FI90662C FI90662C (sv) 1994-03-10

Family

ID=26327181

Family Applications (1)

Application Number Title Priority Date Filing Date
FI892420A FI90662C (sv) 1988-05-20 1989-05-19 Förfarande för framställning av terapeutiskt användbara 2-aminoetanolderivat

Country Status (15)

Country Link
US (1) US4960788A (sv)
EP (1) EP0342613B1 (sv)
JP (1) JP2802437B2 (sv)
AU (1) AU624382B2 (sv)
CA (1) CA1336333C (sv)
DE (1) DE68903425T2 (sv)
DK (1) DK172008B1 (sv)
ES (1) ES2043943T3 (sv)
FI (1) FI90662C (sv)
GR (1) GR3006803T3 (sv)
HU (1) HU208420B (sv)
IE (1) IE61631B1 (sv)
IL (1) IL90324A0 (sv)
NO (1) NO174463C (sv)
SU (1) SU1727531A3 (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2653123B1 (fr) * 1989-10-17 1992-01-17 Roussel Uclaf Nouveaux derives de la pyridone, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
IT1239950B (it) * 1990-03-28 1993-11-27 Zambon Spa Processo per la preparazione di composti con attivita' analgesica centrale
US5208345A (en) * 1990-12-17 1993-05-04 Merrell Dow Pharmaceuticals Inc. Process for the production of (S)-vinyl and allenyl gaba
IL100360A (en) * 1990-12-17 1998-08-16 Merrell Dow Pharma HISTORY OF PYROLIDINONE USED AS SUBSTANCE (S) -Vinyl and Alanyl GABA
WO2004069793A2 (en) 2003-01-28 2004-08-19 Bristol-Myers Squibb Company Novel 2-substituted cyclic amines as calcium sensing receptor modulators
US7205322B2 (en) 2003-02-12 2007-04-17 Bristol-Myers Squibb Company Thiazolidine compounds as calcium sensing receptor modulators
US7265145B2 (en) 2003-05-28 2007-09-04 Bristol-Myers Squibb Company Substituted piperidines and pyrrolidines as calcium sensing receptor modulators and method
WO2007065634A1 (en) * 2005-12-07 2007-06-14 Ucb Pharma, S.A. 3-carboxy- 2-oxo-1 -pyrrolidine derivatives and their uses
CN115475162B (zh) * 2022-10-18 2023-06-02 浙江震元制药有限公司 4-异丁基-2-吡咯烷酮在制备镇痛药物中的应用、一种镇痛药物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2496163A (en) * 1948-03-30 1950-01-31 Du Pont Synthesis of a 2-substituted-5-oxopyrrolidine
BE790747A (fr) * 1971-10-30 1973-02-15 Whitefin Holding Sa Stereo-isomeres du 1-(1'-(0-chloro-benzyl)-pyrrol-2'-yl) -2-dibutyl sec.-amino-ethanol et procede pour leur preparation
IE45511B1 (en) * 1976-09-01 1982-09-08 Ciba Geigy Ag New derivatives of perhydro-aza-heterocycles and processesfor the production thereof
US4525476A (en) * 1983-05-26 1985-06-25 Warner-Lambert Company N-[1-oxo-3-(5-oxo-2-pyrrolidinyl)propyl]-alpha-aminoacids and derivatives as cognition activators
FR2549053B1 (fr) * 1983-07-12 1985-12-27 Sanofi Sa Nouveaux derives de la pyrrolidine actifs sur le systeme nerveux central, leur procede de preparation, les medicaments en contenant
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
DE3420193A1 (de) * 1984-05-30 1985-12-05 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte pyrrolidinone, verfahren zu ihrer herstellung und arzneimittel

Also Published As

Publication number Publication date
IE891578L (en) 1989-11-20
DE68903425T2 (de) 1993-03-25
IE61631B1 (en) 1994-11-16
FI892420A (sv) 1989-11-21
JP2802437B2 (ja) 1998-09-24
NO892021D0 (no) 1989-05-19
HU208420B (en) 1993-10-28
NO174463B (no) 1994-01-31
NO892021L (no) 1989-11-21
DK244389A (da) 1989-12-20
DE68903425D1 (de) 1992-12-17
HUT50765A (en) 1990-03-28
JPH0217176A (ja) 1990-01-22
DK172008B1 (da) 1997-09-15
IL90324A0 (en) 1989-12-15
CA1336333C (en) 1995-07-18
AU624382B2 (en) 1992-06-11
SU1727531A3 (ru) 1992-04-15
EP0342613B1 (en) 1992-11-11
FI90662B (sv) 1993-11-30
NO174463C (no) 1994-05-11
GR3006803T3 (sv) 1993-06-30
ES2043943T3 (es) 1994-01-01
AU3499389A (en) 1989-11-23
US4960788A (en) 1990-10-02
DK244389D0 (da) 1989-05-19
FI90662C (sv) 1994-03-10
EP0342613A1 (en) 1989-11-23

Similar Documents

Publication Publication Date Title
FI104170B1 (sv) Förfarande för framställning av terapeutiskt användning 3-aminopyrazolderivat
FI890282A0 (sv) Förfarande för framställning av terapeutiskt användbara 23,24-didehydro-25-hydroxikalciferolderivat
FI905941A (sv) Förfarande för framställning av terapeutiskt användbara heterocykliska 2-acylaminotiazolderivat
FI96861C (sv) Förfarande för framställning av terapeutiskt aktiva substituerade indolylpyrrolderivat
FI92934B (sv) Analogiförfarande för framställning av terapeutiskt användbara 1-deoxinojirimycinderivat
FI892881A (sv) Förfarande för framställning av terapeutiskt användbara aminosyraderivat
FI874459A (sv) Förfarande för framställning av terapeutiskt användbara piperidinderivat
FI892182A (sv) Förfarande för framställning av terapeutiskt användbara kromanderivat
FI92696C (sv) Förfarande för framställning av terapeutiskt användbara tiazolidindionderivat
FI890072A (sv) Förfarande för framställning av farmaceutiskt användbara isokinolinderivat
FI90877C (sv) Förfarande för framställning av nya terapeutiskt användbara aristeromycin/adenosinderivat
FI883672A (sv) Förfarande för framställning av terapeutiskt användbara aminoalkoxifenylderivat
FI895393A0 (sv) Förfarande för framställning av terapeutiskt användbara alkylsubstituerade-2-alkylaminbensopyran-6-oler
FI93106C (sv) Förfarande för framställning av som läkemedel användbara 2-iminobenzotiazolinderivat
FI892948A0 (sv) Förfarande för framställning av terapeutiskt användbara kromanderivat
FI893003A (sv) Förfarande för framställning av terapeutiskt användbara neplanocinderivat
FI95701C (sv) Förfarande för framställning av terapeutiskt användbara kromanderivat
FI92825C (sv) Förfarande för framställning av terapeutiskt användbara kromanderivat
FI895983A0 (sv) Förfarande för framställning av som läkemedel användbara 2-benzotiazolinderivat
FI92064C (sv) Förfarande för framställning av terapeutiskt användbara N-bensopyranyllaktamer
FI911420A (sv) Förfarande för framställning av terapeutiskt användbara föreningar
FI892420A0 (sv) Förfarande för framställning av terapeutiskt användbara 2-aminoetanolderivat
FI893002A0 (sv) Förfarande för framställning av terapeutiskt användbara peptidderivater
FI884473A (sv) Förfarande för framställning av terapeutiskt användbara fenoxialkylpyrokatekolderivat
NO176915C (no) Fremgangsmåte for fremstilling av et hirudin-derivat

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: ZAMBON GROUP S.P.A.